Preliminary Effects of Hydrogen-Oxygen Inhalation on Nodule Size, IL-6, and Neutrophils in Patients with Small Pulmonary Nodules
Wei Xiaohui, Zhang Wei, Li Yuanyuan, Sha Xiaojuan, Yi Hongpeng, Cui Chao · Drug Design, Development and Therapy · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This record describes a planned hydrogen study; no treatment result is available yet.
Oxyhydrogen hydrogen research study 2026: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This registered clinical trial examined Preliminary Effects of Hydrogen-Oxygen Inhalation on Nodule Size, IL-6, and Neutrophils in Patients with Small Pulmonary Nodules. The abstract describes Planned or registered research population; sample size 30; hydrogen delivered as oxyhydrogen; reported duration 3 month. Within the limitations of this single-center, small-sample study with a 3-month follow-up, hydrogen-oxygen inhalation can reduce SPN diameter and downregulate peripheral blood IL-6 and….
Publication: Wei Xiaohui, Zhang Wei, Li Yuanyuan, Sha Xiaojuan, Yi Hongpeng, Cui Chao, Drug Design, Development and Therapy, 2026.
What the researchers studied
To evaluate the effects of hydrogen-oxygen inhalation on nodule diameter and peripheral blood inflammatory factors in patients with small pulmonary nodules (SPNs), and to…
What effects did molecular hydrogen have?
No treatment effects have been reported yet. This publication describes a planned study rather than completed results.
Why these findings matter
This publication describes how a study is planned. It cannot yet support a conclusion about hydrogen’s therapeutic potential because completed results have not been reported.
How strong is this evidence?
This is a study protocol, so no completed outcome evidence is available yet. The reported sample size was 30. Comparison or control: Control group reported.
Technical study details
- Publication type: Registered clinical trial
- Evidence type: Protocol or ongoing research
- Research model or population: Planned or registered research population
- Sample size: 30
- Control or comparison: Control group reported
- Hydrogen method: Oxyhydrogen
- Treatment duration: 3 month
Limitations and safety
Important limitations: The abstract alone may not report all methodological limitations; full-text review is required.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.